(Q44639840)

4 December 2017

title

Cost-analysis of PCR-guided pre-emptive antibiotic treatment of Staphylococcus aureus infections: an analytic decision model (English)

1 reference

4 December 2017

main subject

Staphylococcus aureus

1 reference

C Hübner

1

1 reference

4 December 2017

N-O Hübner

series ordinal

2

1 reference

4 December 2017

A Kramer

series ordinal

3

1 reference

4 December 2017

S Fleßa

series ordinal

4

1 reference

4 December 2017

publication date

15 June 2012

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

4 December 2017

published in

1 reference

4 December 2017

volume

31

1 reference

4 December 2017

issue

11

1 reference

4 December 2017

page(s)

3065-3072

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-012-1666-y

4 December 2017

exact match

0 references

cites work

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Predictive value and cost-effectiveness analysis of a rapid polymerase chain reaction for preoperative detection of nasal carriage of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Transmission rates, screening methods and costs of MRSA--a systematic literature review related to the prevalence in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

The effect of antibiotics on methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1666-Y

Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22699792

12 December 2020

inferred from PubMed ID database lookup

The role of DNA amplification technology in the diagnosis of infectious diseases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22699792

12 December 2020

inferred from PubMed ID database lookup

Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22699792

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10096-012-1666-Y

1 reference

release_xrwmds7xerfaxbbfwyrequhxgi

4 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xrwmds7xerfaxbbfwyrequhxgi

24 November 2022

mapped directly with Wikidata item

1 reference